Cargando…
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
New generation plasmid DNA vaccines may be a safe, fast and simple emergency vaccine platform for preparedness against emerging viral pathogens. Applying platform optimization strategies, we tested the pre-clinical immunogenicity and protective effect of a candidate DNA plasmid vaccine specific for...
Autores principales: | Lassaunière, Ria, Polacek, Charlotta, Gram, Gregers J., Frische, Anders, Tingstedt, Jeanette Linnea, Krüger, Maren, Dorner, Brigitte G., Cook, Anthony, Brown, Renita, Orekov, Tatyana, Putmon-Taylor, Tammy, Campbell, Tracey-Ann, Greenhouse, Jack, Pessaint, Laurent, Andersen, Hanne, Lewis, Mark G., Fomsgaard, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688418/ https://www.ncbi.nlm.nih.gov/pubmed/34930909 http://dx.doi.org/10.1038/s41541-021-00419-z |
Ejemplares similares
-
Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets
por: Tingstedt, Jeanette Linnea, et al.
Publicado: (2023) -
Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine
por: Lassaunière, Ria, et al.
Publicado: (2022) -
A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies
por: Frische, Anders, et al.
Publicado: (2023) -
Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021
por: Lassaunière, Ria, et al.
Publicado: (2021) -
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay
por: Frische, Anders, et al.
Publicado: (2022)